Brain growth trajectories in mouse strains with central and peripheral serotonin differences: Relevance to autism models

Neuroscience

Volumn 210, Issue , 2012, Pages 286-295

  Flood, Z C ^a   Engel, D L J ^a   Simon, C C ^a   Negherbon, K R ^a   Murphy, L J ^a   Tamavimok, W ^a   Anderson, G M ^b   Janusonis S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT; Autism; Blood; Brain growth; Hippocampus; Postnatal

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BAGG ALBINO MOUSE; BRAIN GROWTH; BRAIN SIZE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; GENE; HIPPOCAMPUS; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL BEHAVIOR; SOMATOSENSORY CORTEX; STRAIN DIFFERENCE; THP2 GENE;

ANIMALS; AUTISTIC DISORDER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SEROTONIN;

EID: 84861198527     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.010     Document Type: Article

References (85)

1. Adamsen D., Meili D., Blau N., Thony B., Ramaekers V. Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants. Mol Genet Metab 2011, 102:368-373.
2. Albay R., Chen A., Anderson G.M., Tatevosyan M., Janušonis S. Relationships among body mass, brain size, gut length, and blood tryptophan and serotonin in young wild-type mice. BMC Physiol 2009, 9:4.
3. Altamura C., Dell'Acqua M.L., Moessner R., Murphy D.L., Lesch K.P., Persico A.M. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb Cortex 2007, 17:1394-1401.
4. Anderson GM, Hertzig ME, McBride PA (in press) Brief report: platelet-poor plasma serotonin in autism. J Autism Dev Disord, in press.
5. Anderson G.M., Horne W.C., Chatterjee D., Cohen D.J. The hyperserotonemia of autism. Ann N Y Acad Sci 1990, 600:331-340.
6. Anderson G.M., Stevenson J.M., Cohen D.J. Steady-state model for plasma free and platelet serotonin in man. Life Sci 1987, 41:1777-1785.
7. Azmitia E.C., Singh J.S., Whitaker-Azmitia P.M. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011, 60:1347-1354.
8. Bach H., Arango V., Huang Y.Y., Leong S., Mann J.J., Underwood M.D. Neuronal tryptophan hydroxylase expression in BALB/cJ and C57Bl/6J mice. J Neurochem 2011, 118:1067-1074.
9. Baker J.R. Principles of biological microtechnique 1958, Methuen & Co, Ltd, London.
10. Bangash M.A., Park J.M., Melnikova T., Wang D., Jeon S.K., Lee D., Syeda S., Kim J., Kouser M., Schwartz J., Cui Y., Zhao X., Speed H.E., Kee S.E., Tu J.C., Hu J.H., Petralia R.S., Linden D.J., Powell C.M., Savonenko A., Xiao B., Worley P.F. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 2011, 145:758-772.
11. Betancur C. Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. Brain Res 2011, 1380:42-77.
12. Blinkov S.M., Glezer I.I. The human brain in figures and tables: a quantitative handbook 1968, Plenum Press, New York.
13. Bonnin A., Goeden N., Chen K., Wilson M.L., King J., Shih J.C., Blakely R.D., Deneris E.S., Levitt P. A transient placental source of serotonin for the fetal forebrain. Nature 2011, 472:347-350.
14. Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
15. Brodkin E.S. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav Brain Res 2007, 176:53-65.
16. Butler A.B., Hodos W. Comparative vertebrate neuroanatomy: evolution and adaptation 2005, John Wiley & Sons, Inc, Hoboken. (2nd ed.).
17. Carneiro A.M., Airey D.C., Thompson B., Zhu C.B., Lu L., Chesler E.J., Erikson K.M., Blakely R.D. Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci U S A 2009, 106:2047-2052.
18. Carneiro A.M., Cook E.H., Murphy D.L., Blakely R.D. Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 2008, 118:1544-1552.
19. Carter M.D., Shah C.R., Muller C.L., Crawley J.N., Carneiro A.M., Veenstra-VanderWeele J. Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions. Autism Res 2011, 4:57-67.
20. Casey J.P., Magalhaes T., Conroy J.M., Regan R., Shah N., et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 2012, 131:565-579.
21. Chugani D.C. Role of altered brain serotonin mechanisms in autism. Mol Psychiatry 2002, 7(Suppl 2):S16-S17.
22. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999, 45:287-295.
23. 4 receptor knock-out mice. J Neurosci 2004, 24:412-419.
24. Cook E.H. Brief report: pathophysiology of autism: neurochemistry. J Autism Dev Disord 1996, 26:221-225.
25. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2011, 1380:138-145.
26. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
27. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., Chisum H.J., Moses P., Pierce K., Lord C., Lincoln A.J., Pizzo S., Schreibman L., Haas R.H., Akshoomoff N.A., Courchesne R.Y. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001, 57:245-254.
28. Coutinho A.M., Sousa I., Martins M., Correia C., Morgadinho T., Bento C., Marques C., Ataide A., Miguel T.S., Moore J.H., Oliveira G., Vicente A.M. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 2007, 121:243-256.
29. Eagleson K.L., Campbell D.B., Thompson B.L., Bergman M.Y., Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res 2011, 4:68-83.
30. Epstein H.T. The effect of litter size on weight gain in mice. J Nutr 1978, 108:120-123.
31. Ey E., Leblond C.S., Bourgeron T. Behavioral profiles of mouse models for autism spectrum disorders. Autism Res 2011, 4:5-16.
32. Fairless A.H., Dow H.C., Toledo M.M., Malkus K.A., Edelmann M., Li H., Talbot K., Arnold S.E., Abel T., Brodkin E.S. Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain. Brain Res 2008, 1230:211-217.
33. Fairless A.H., Shah R.Y., Guthrie A.J., Li H., Brodkin E.S. Deconstructing sociability, an autism-relevant phenotype, in mouse models. Anat Rec 2011, 294:1713-1725.
34. Gershon M.D., Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 132:397-414.
35. Groen W., Teluij M., Buitelaar J., Tendolkar I. Amygdala and hippocampus enlargement during adolescence in autism. J Am Acad Child Adolesc Psychiatry 2010, 49:552-560.
36. 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
37. Hanley H.G., Stahl S.M., Freedman D.X. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 1977, 34:521-531.
38. 1A receptor mutant mice. Proc Natl Acad Sci U S A 1998, 95:15049-15054.
39. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
40. Hranilovic D., Bujas-Petkovic Z., Vragovic R., Vuk T., Hock K., Jernej B. Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord 2007, 37:1934-1940.
41. Insel T.R., Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc Natl Acad Sci U S A 1992, 89:5981-5985.
42. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 1992, 72:165-229.
43. Janušonis S. Statistical distribution of blood serotonin as a predictor of early autistic brain abnormalities. Theor Biol Med Model 2005, 2:27.
44. Janušonis S. Origin of the blood hyperserotonemia of autism. Theor Biol Med Model 2008, 5:10.
45. Janušonis S. Comparing two small samples with an unstable, treatment-independent baseline. J Neurosci Methods 2009, 179:173-178.
46. Janušonis S. Relationships among variables and their equlibrium values: caveats of time-less interpretation. Biol Rev Camb Philos Soc 2012, 87:275-289.
47. 1A receptor knockout mice: potential relevance to the neurobiology of autism. J Neurochem 2006, 99:1019-1031.
48. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., Whitaker-Azmitia P.M. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 2002, 75:403-410.
49. Lazic S.E. The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?. BMC Neurosci 2010, 11:5.
50. Lewis S. Autism: grooming mice to model autism. Nat Rev Neurosci 2011, 12:248-249.
51. Lillesaar C. The serotonergic system in fish. J Chem Neuroanat 2011, 41:294-308.
52. Macdonald M.W. The Princeton encyclopedia of mammals 2006, Princeton University Press, Princeton.
53. McBride P.A., Anderson G.M., Hertzig M.E., Snow M.E., Thompson S.M., Khait V.D., Shapiro T., Cohen D.J. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry 1998, 37:767-776.
54. McNamara I.M., Borella A.W., Bialowas L.A., Whitaker-Azmitia P.M. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res 2008, 1189:203-214.
55. Melke J., Goubran B.H., Chaste P., Betancur C., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Gillberg I.C., Delorme R., Chabane N., Mouren-Simeoni M.C., Fauchereau F., Durand C.M., Chevalier F., Drouot X., Collet C., Launay J.M., Leboyer M., Gillberg C., Bourgeron T. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008, 13:90-98.
56. Mercier F., Cho K.Y., Kodama R. Meningeal/vascular alterations and loss of extracellular matrix in the neurogenic zone of adult BTBR T+ tf/J mice, animal model for autism. Neurosci Lett 2011, 498:173-178.
57. Mulder E.J., Anderson G.M., Kema I.P., de Bildt A., Van Lang N.D., Den Boer J.A., Minderaa R.B. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry 2004, 43:491-499.
58. Nakagawa S., Hauber M.E. Great challenges with few subjects: statistical strategies for neuroscientists. Neurosci Biobehav Rev 2011, 35:462-473.
59. Narayan M., Srinath S., Anderson G.M., Meundi D.B. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993, 33:630-635.
60. Pappas P.W. The use of a chrome alum-gelatin (subbing) solution as a general adhesive for paraffin sections. Stain Technol 1971, 46:121-124.
61. 1A receptor. Proc Natl Acad Sci U S A 1998, 95:10734-10739.
62. Pinheiro J., Bates D., DebRoy S., Sarkar D. nlme: linear and nonlinear mixed effects models. R Foundation for Statistical Computing 3.1 2011, (www.r-project.org).
63. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 1998, 95:14476-14481.
64. Robinson G.E., Fernald R.D., Clayton D.F. Genes and social behavior. Science 2008, 322:896-900.
65. Roderick T.H., Wimer R.E., Wimer C.C., Schwartzkroin P.A. Genetic and phenotypic variation in weight of brain and spinal cord between inbred strains of mice. Brain Res 1973, 64:345-353.
66. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961, 58:315-320.
67. Schumann C.M., Hamstra J., Goodlin-Jones B.L., Lotspeich L.J., Kwon H., Buonocore M.H., Lammers C.R., Reiss A.L., Amaral D.G. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 2004, 24:6392-6401.
68. Siesser W.B., Zhang X., Jacobsen J.P., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice. Neurosci Lett 2010, 481:6-11.
69. Silverman J.L., Yang M., Lord C., Crawley J.N. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010, 11:490-502.
70. Spencer C.M., Alekseyenko O., Hamilton S.M., Thomas A.M., Serysheva E., Yuva-Paylor L.A., Paylor R. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res 2011, 4:40-56.
71. Stephenson D.T., O'Neill S.M., Narayan S., Tiwari A., Arnold E., Samaroo H., Du F., Ring R., Campbell B., Pletcher M., Vaidya V.A., Morton D. Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Mol Autism 2011, 2:7.
72. Turner L.M., Young A.R., Römpler H., Schoneberg T., Phelps S.M., Hoekstra H.E. Monogamy evolves through multiple mechanisms: evidence from V1aR in deer mice. Mol Biol Evol 2010, 27:1269-1278.
73. van der Staay F.J., Arndt S.S., Nordquist R.E. Evaluation of animal models of neurobehavioral disorders. Behav Brain Func 2009, 5:11.
74. Veenstra-Vanderweele J., Muller C.L., Iwamoto H., Sauer J.E., Owens W.A., Shah C.R., Cohen J., Mannangatti P., Jessen T., Thompson B.J., Ye R., Kerr T.M., Carneiro A.M., Crawley J.N., Sanders-Bush E., McMahon D.G., Ramamoorthy S., Daws L.C., Sutcliffe J.S., Blakely R.D. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 2012, 109:5469-5474.
75. Vitalis T., Cases O., Passemard S., Callebert J., Parnavelas J.G. Embryonic depletion of serotonin affects cortical development. Eur J Neurosci 2007, 26:331-344.
76. Wahlsten D., Hudspeth W.J., Bernhardt K. Implications of genetic variation in mouse brain structure for electrode placement by stereotaxic surgery. J Comp Neurol 1975, 162:519-531.
77. Wassink T.H., Hazlett H.C., Epping E.A., Arndt S., Dager S.R., Schellenberg G.D., Dawson G., Piven J. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 2007, 64:709-717.
78. Weiss L.A., Kosova G., Delahanty R.J., Jiang L., Cook E.H., Ober C., Sutcliffe J.S. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet 2006, 14:923-931.
79. Weiss L.A., Veenstra-VanderWeele J., Newman D.L., Kim S.J., Dytch H., McPeek M.S., Cheng S., Ober C., Cook E.H., Abney M. Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet 2004, 12:949-954.
80. Wimer R.E., Wimer C.C., Roderick T.H. Genetic variability in forebrain structures between inbred strains of mice. Brain Res 1969, 16:257-264.
81. Wöhr M., Roullet F.I., Hung A.Y., Sheng M., Crawley J.N. Communication impairments in mice lacking shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS ONE 2011, 6:e20631.
82. Woods V.E., Epstein H.T. Three parameters affecting interlitter variations. Dev Psychobiol 1979, 12:317-328.
83. Yochum C.L., Medvecky C.M., Cheh M.A., Bhattacharya P., Wagner G.C. Differential development of central dopaminergic and serotonergic systems in BALB/c and C57BL/6J mice. Brain Res 2010, 1349:97-104.
84. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004, 305. 217-217.
85. Zuur A.F., Ieno E.N., Walker N.J., Saveliev A.A., Smith G.M. Mixed effects models and extensions in ecology with R 2009, Springer, New York.